BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33445216)

  • 1. The role of sarcopenic obesity in high-grade endometrial cancer.
    Donkers H; Fasmer KE; Mcgrane J; Pijnenborg JMA; Bekkers R; Haldorsen IS; Galaal K
    Int J Gynaecol Obstet; 2021 Aug; 154(2):248-255. PubMed ID: 33445216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer.
    Kuroki LM; Mangano M; Allsworth JE; Menias CO; Massad LS; Powell MA; Mutch DG; Thaker PH
    Ann Surg Oncol; 2015 Mar; 22(3):972-9. PubMed ID: 25190123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and visceral fat: Survival impact in high-grade endometrial cancer.
    Donkers H; Fasmer KE; Mcgrane J; Pijnenborg JMA; Bekkers R; Haldorsen IS; Galaal K
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():425-432. PubMed ID: 33307325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
    Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT Body Composition of Sarcopenia and Sarcopenic Obesity: Predictors of Postoperative Complications and Survival in Patients with Locally Advanced Esophageal Adenocarcinoma.
    Fehrenbach U; Wuensch T; Gabriel P; Segger L; Yamaguchi T; Auer TA; Beetz NL; Denecke C; Kröll D; Raakow J; Knitter S; Chopra S; Thuss-Patience P; Pratschke J; Hamm B; Biebl M; Geisel D
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient's Skeletal Muscle Radiation Attenuation and Sarcopenic Obesity are Associated with Postoperative Morbidity after Neoadjuvant Chemoradiation and Resection for Rectal Cancer.
    Berkel AEM; Klaase JM; de Graaff F; Brusse-Keizer MGJ; Bongers BC; van Meeteren NLU
    Dig Surg; 2019; 36(5):376-383. PubMed ID: 29898443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
    Kocher NJ; Jafri S; Balabhadra S; Lehman E; Gardner J; Vijay K; Sarwani N; Raman JD
    Urol Oncol; 2018 Apr; 36(4):156.e17-156.e22. PubMed ID: 29276063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
    Şahin MEH; Akbaş F; Yardimci AH; Şahin E
    BMC Cancer; 2023 Sep; 23(1):911. PubMed ID: 37770828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.
    Bonavolontà P; Improta G; Dell'Aversana Orabona G; Goglia F; Abbate V; Sorrentino A; Piloni S; Salzano G; Iaconetta G; Califano L
    J Craniomaxillofac Surg; 2023 Jan; 51(1):7-15. PubMed ID: 36739189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of sarcopenia and sarcopenic obesity on survival in children with Ewing sarcoma and osteosarcoma.
    Buğdaycı O; Eker N
    Pediatr Radiol; 2023 May; 53(5):854-861. PubMed ID: 36600101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
    Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
    Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is sarcopenia a better predictor of complications than body mass index? Sarcopenia and surgical outcomes in patients with rectal cancer.
    Jochum SB; Kistner M; Wood EH; Hoscheit M; Nowak L; Poirier J; Eberhardt JM; Saclarides TJ; Hayden DM
    Colorectal Dis; 2019 Dec; 21(12):1372-1378. PubMed ID: 31276286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Kamo N; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yao S; Yagi S; Uemoto S
    Clin Nutr; 2019 Oct; 38(5):2202-2209. PubMed ID: 30482562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
    Chen BB; Liang PC; Shih TT; Liu TH; Shen YC; Lu LC; Lin ZZ; Hsu C; Hsu CH; Cheng AL; Shao YY
    Eur Radiol; 2023 Jan; 33(1):512-522. PubMed ID: 35864351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implication of preoperative psoas muscle area in endometrial cancer patients.
    Bilir F; Özgül E; Elaziz B; Arıöz DT
    Rev Assoc Med Bras (1992); 2021 Dec; 67(12):1759-1763. PubMed ID: 34909946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.